Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra for prevention of febrile neutropenia and mucositis after high-dose melphalan autologous stem cell transplantation
NL-OMON48856Phase 2Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2019
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in mucositis and febrile neutropenia (FN) comparing Anakinra with Placebo (2 arms). Primary endpoint: Incidence of fever during neutropenia. Started Oct 2019; status: recruiting.
02
Drugs
anakinra
03
Conditions
mucositisfebrile neutropenia (FN)
Beyond the preview
Go deeper on NL-OMON48856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48856.